Advice about aging well is everywhere. One headline insists that a certain food will extend your life, while another warns that the same ingredient accelerates decline. Between wellness trends, dietary fads and supplement marketing, it can be difficult to distinguish scientific evidence from speculation. Yet among the many competing approaches to longevity, one strategy has consistently attracted serious scientific interest for decades: eating less.

Known as caloric restriction, fasting or dietary restriction, the practice involves reducing calorie intake either continuously or within specific time periods while still maintaining proper nutrition. Researchers have repeatedly observed that caloric restriction can improve markers of health and longevity across multiple species. The challenge, however, is practical as much as biological.

As Eduardo Chini explains, food is deeply tied to pleasure, culture and social connection. Restricting calories indefinitely may offer physiological benefits, but it can also diminish quality of life. This tension has inspired a new scientific question: can medicine reproduce the benefits of caloric restriction without requiring people to permanently eat less?

At the center of this research is an intricate network of cellular processes that govern metabolism, inflammation and aging itself.

The Scientific Interest in Eating Less

For decades, studies in animals have suggested that caloric restriction can extend lifespan and reduce the risk of age-related diseases. Scientists believe the benefits stem not merely from weight loss, but from deeper biological changes triggered when the body senses limited nutrient availability.

During periods of fasting or reduced calorie intake, cells alter how they produce energy, repair damage and respond to stress. These adaptations appear to improve cellular resilience and reduce chronic inflammation, both of which are strongly associated with aging.

Researchers are particularly interested in whether these biological effects can be isolated and activated therapeutically. If successful, such treatments could potentially help address diseases associated with aging, including metabolic disorders, neurodegenerative conditions and chronic inflammatory diseases.

Eduardo Chini and the Biology of Aging

Dr. Chini, an anesthesiologist and researcher at the Robert and Arlene Kogod Center on Aging, has spent decades studying the molecular mechanisms behind caloric restriction.

Although anesthesiology may seem unrelated to aging research, Dr. Chini’s work bridges multiple medical disciplines. His clinical background gives him exposure to a broad range of diseases, while his scientific focus centers on metabolism — the vast network of chemical reactions that sustain life at the cellular level.

His team’s work investigates how cells generate energy, repair themselves and communicate under stress. Over time, this research led them to a molecule now considered central to understanding aging biology: NAD+.

NAD+: A Critical Molecule in Cellular Health

NAD+, short for nicotinamide adenine dinucleotide, is essential for cellular function. The body produces it from nutrients including tryptophan and forms of vitamin B3 such as nicotinamide and nicotinamide riboside.

NAD+ supports hundreds of enzymatic reactions throughout the body. It helps cells generate energy, repair DNA and maintain protein integrity. Without adequate NAD+ levels, normal cellular processes begin to deteriorate.

One of the most significant discoveries in aging research is that NAD+ levels decline naturally with age. Scientists increasingly suspect that this decline contributes to many diseases and dysfunctions associated with aging.

For years, researchers did not fully understand how NAD+ was regulated or broken down. Dr. Chini’s laboratory helped clarify that process through the discovery of a key enzyme called CD38.

CD38 and the Decline of NAD+

In 2002, Dr. Chini’s team identified CD38 as a major enzyme responsible for degrading NAD+ in the body. This finding significantly advanced understanding of why NAD+ levels decrease over time.

Subsequent research linked elevated CD38 activity to several hallmarks of aging, including chronic inflammation, dysfunctional mitochondria and the accumulation of senescent cells — damaged cells that stop functioning properly but resist natural elimination.

Senescent cells are particularly important in aging research because they contribute to persistent low-grade inflammation. Scientists now describe this chronic inflammatory state as “inflammaging,” a condition believed to underlie many age-related diseases.

In studies involving aged mice, researchers found that increasing numbers of immune cells expressing CD38 corresponded with declining NAD+ levels. These findings suggested that immune system activity and chronic inflammation may play a central role in the biological aging process.

From Laboratory Discovery to Potential Therapies

The implications of this work extend beyond academic understanding. Researchers are now exploring whether therapies that inhibit CD38 or restore NAD+ levels could replicate some benefits of caloric restriction.

Dr. Chini’s team is collaborating with pharmaceutical partners to investigate drugs that may block CD38 activity. The goal is not simply to extend lifespan, but to improve health span — the period of life spent in good health and functional independence.

This approach reflects a broader trend in modern aging research: targeting the biological mechanisms of aging itself rather than treating diseases only after they emerge.

If scientists can successfully mimic the cellular effects of caloric restriction through medication, patients may one day benefit from improved metabolic and inflammatory health without maintaining strict dietary regimens.

The Future of Aging Research

The study of aging has evolved dramatically over the past two decades. What was once considered an inevitable biological decline is now increasingly viewed as a process influenced by identifiable molecular pathways.

Research into NAD+, CD38 and caloric restriction illustrates how interconnected metabolism, immunity and cellular repair truly are. It also demonstrates how discoveries in basic science can gradually move toward clinical application.

While many questions remain unanswered, the work underway at institutions such as Mayo Clinic represents a growing effort to translate longevity science into practical medicine.

For now, caloric restriction remains one of the most consistently studied interventions in aging biology. Whether future therapies can reproduce its effects safely and effectively remains uncertain. But for researchers and patients alike, the possibility offers a compelling vision: preserving health and vitality without sacrificing the everyday pleasures that make life enjoyable — including, perhaps, the occasional slice of cake.

What do you think about this article? Please share it and comment.

You would like to ask a question, publish an article with us or place and advertisement? Please contact us.